What would it cost to license or adopt this technology?+
No pricing or licensing model is publicly available in the project data. As a publicly funded EU research project (RIA), the IP is typically held by the consortium partners. A licensing discussion would need to go through the coordinator at the University of Genova or the 2 industry partners in the consortium.
Can this work at industrial scale or is it still a lab experiment?+
The project completed proof-of-concept testing and validation in multiple real-world scenarios — chronic pain management, disability support, dance, sports, and entertainment. Summative evaluations included both lab and in-situ (real environment) studies. However, this was a FET Proactive research project, so scaling to commercial products would require further engineering and productization.
Who owns the intellectual property?+
As a Horizon 2020 RIA project, IP is typically owned by the partners who generated it. The consortium includes 12 partners across 8 countries, with 2 industry partners and 9 universities. Licensing negotiations would likely involve the University of Genova as coordinator and the specific partners who developed the technology components you need.
What specific movement analysis capabilities were validated?+
The project validated proof-of-concepts in 3 distinct domains: (1) dance, living architectures, sports and entertainment, (2) healing and everyday life support for people with disabilities, and (3) chronic pain management. Each underwent summative evaluation with user interviews, observations, and effectiveness assessments. The project produced 47 deliverables total.
How does this differ from existing motion capture systems?+
Based on the project objectives, the key differentiator is multi-layered time analysis — the system processes movement at multiple time scales simultaneously, from split-second reactions to gradual behavioral changes. Standard motion capture tracks position; this technology aims to detect, measure, and predict movement qualities and synchronization between people.
What is the timeline to get a working product from this research?+
The project ended in December 2022 with validated proof-of-concepts. Moving from proof-of-concept to a commercial product would require productization, regulatory considerations (especially for healthcare applications), and integration engineering. Based on available project data, the technology is at the tested stage, likely requiring 2-3 more years of development for market-ready products.
Is there regulatory approval for healthcare use?+
Based on available project data, no regulatory approvals (CE marking, medical device certification) are mentioned. The healthcare proof-of-concepts were validated in controlled and ecological studies, but regulatory clearance for clinical use as a medical device would be an additional step beyond the project scope.
